Clinical Research Directory
Browse clinical research sites, groups, and studies.
PK Subtrial in Adolescent Patients With HAE Type I or II Participating in the KVD900-302 Trial
Sponsor: KalVista Pharmaceuticals, Ltd.
Summary
This is a multicenter pharmacokinetic (PK) subtrial to investigate the PK profile of KVD900 (sebetralstat) in adolescent patients 12 to 17 years of age with Hereditary Angioedema (HAE) type I or II.
Official title: A Pharmacokinetic Subtrial in Adolescent Patients With Hereditary Angioedema Type I or II Participating in the KVD900-302 Trial
Key Details
Gender
All
Age Range
12 Years - 17 Years
Study Type
INTERVENTIONAL
Enrollment
11
Start Date
2022-10-24
Completion Date
2026-06-30
Last Updated
2025-07-18
Healthy Volunteers
No
Conditions
Interventions
KVD900 600 mg
KVD900 Tablet 600 mg (2 x 300 mg)
Drug: KVD900 300 mg
KVD900 Tablet 300 mg
Locations (61)
KalVista Investigative Site
Scottsdale, Arizona, United States
KalVista Investigative Site
Little Rock, Arkansas, United States
KalVista Investigative Site
San Diego, California, United States
KalVista Investigative Site
San Diego, California, United States
KalVista Investigative Site
Santa Monica, California, United States
KalVista Investigative Site
Centennial, Colorado, United States
KalVista Investigative Site
Colorado Springs, Colorado, United States
KalVista Investigative Site
Evansville, Indiana, United States
KalVista Investigative Site
Overland Park, Kansas, United States
KalVista Investigative Site
Louisville, Kentucky, United States
KalVista Investigative Site
Chevy Chase, Maryland, United States
KalVista Investigative Site
Plymouth, Minnesota, United States
KalVista Investigative Site
St Louis, Missouri, United States
KalVista Investigative Site
Charlotte, North Carolina, United States
KalVista Investigative Site
Cincinnati, Ohio, United States
KalVista Investigative Site
Toledo, Ohio, United States
Kalvista Investigative Site
Hershey, Pennsylvania, United States
KalVista Investigative Site
Dallas, Texas, United States
KalVista Investigative Site
Layton, Utah, United States
KalVista Investigative Site
Spokane, Washington, United States
KalVista Investigative Site
Campbelltown, Australia
KalVista Investigative Site
Vienna, Austria
KalVista Investigative Site
Sofia, Bulgaria
KalVista Investigative Site
Montreal, Canada
KalVista Investigative Site
Grenoble, France
KalVista Investigative Site
Lille, France
KalVista Investigative Site
Paris, France
KalVista Investigative Site
Berlin, Germany
KalVista Investigative Site
Frankfurt, Germany
KalVista Investigative Site
Mainz, Germany
KalVista Investigative Site
Mörfelden-Walldorf, Germany
KalVista Investigative Site
Athens, Greece
KalVista Investigative Site
Athens, Greece
KalVista Investigative Site
Haifa, Israel
KalVista Investigative Site
Petach Tikvah, Israel
KalVista Investigative Site
Ramat Gan, Israel
KalVista Investigative Site
Tel Aviv, Israel
KalVista Investigative Site
Sapporo, Hokkaido, Japan
KalVista Investigative Site
Chiba, Japan
KalVista Investigative Site
Hiroshima, Japan
KalVista Investigative Site
Kawagoe-shi, Japan
KalVista Investigative Site
Maebashi, Japan
KalVista Investigative Site
Soka-shi, Japan
KalVista Investigative Site
Takatsuki-shi, Japan
KalVista Investigative Site
Tokyo, Japan
KalVista Investigative Site
Yokohama, Japan
KalVista Investigative Site
Amsterdam, Netherlands
KalVista Investgative Site
Auckland, New Zealand
KalVista Investigative Site
Sângeorgiu de Mureş, Romania
KalVista Investigative Site
Martin, Slovakia
KalVista Investigative Site
Cape Town, South Africa
KalVista Investigative Site
Barcelona, Spain
KalVista Investigative Site
Barcelona, Spain
KalVista Investigative Site
Madrid, Spain
KalVista Investigative Site
Birmingham, United Kingdom
KalVista Investigative Site
Cambridge, United Kingdom
KalVista Investigative Site
Cardiff, United Kingdom
KalVista Investgative Site
Frimley, United Kingdom
KalVista Investigative Site
Leeds, United Kingdom
KalVista Investigative Site
London, United Kingdom
KalVista Investigative Site
London, United Kingdom